Dinamika pendapatan YoY sajrone rolas wulan kepungkur: Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals is developing innovative oral drug delivery methods, including insulin, while diversifying its diabetes research to mitigate startup risks. This daily price action of the trailing 12-month sales growth rate year-over-year on the GURU.Markets terminal chart shows that -100.30 is the current metric value. However, limited capital and the potential for failure in key trials create threats that necessitate the search for new strategic partners.
oramed.com (ORMP) - rincian metrik lan laporan keuangan

This indicator measures revenue dynamics by capturing the percentage deviation of current receipts from the figures of the same period last year. By analyzing the annual growth rate of sales revenue (rolling period), an investor tracks operational efficiency in real time. The TTM calculation method smooths quarterly volatility, revealing sustainable business scaling trends. For Oramed Pharmaceuticals (ORMP), such a metric confirms the ability to generate resources. Excess liquidity and a lack of debt allow Oramed Pharmaceuticals (ORMP) to develop R&D projects independently of short-term sales fluctuations.